Immatics (IMTX) Change in Account Payables (2020 - 2025)
Immatics recorded quarterly Change in Account Payables of $21.9 million in Q4 2025, down 16.78% quarter-over-quarter from $26.3 million in Q3 2025, and down 0.86% year-over-year from $22.1 million in Q4 2024.
Immatics' Change in Account Payables history runs 6 years deep, the most recent figure standing at $21.9 million for Q4 2025.
- In Q4 2025, Change in Account Payables fell 0.86% year-over-year to $21.9 million; the TTM figure through Dec 2025 stood at $21.9 million (down 0.86% YoY), while the FY2025 annual figure was $21.3 million, down 3.78% from the prior year.
- Change in Account Payables came in at $21.9 million for Q4 2025 at Immatics, down from $26.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $36.8 million in Q1 2022 to a low of -$20.1 million in Q4 2021.
- A 5-year average of $15.4 million and a median of $21.4 million in 2025 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables tumbled 82.9% in 2021 and soared 559.27% in 2022, its largest moves.
- Immatics' Change in Account Payables stood at -$20.1 million in 2021, then jumped by 166.34% to $13.3 million in 2022, then soared by 103.6% to $27.1 million in 2023, then declined by 18.46% to $22.1 million in 2024, then dropped by 0.86% to $21.9 million in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods registered $21.9 million, $26.3 million, and $21.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 21.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.92 Mn |
| Dec 31, 2025 | 21.92 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Jun 30, 2025 | 21.17 Mn |
| Jun 30, 2025 | 21.17 Mn |
| Mar 31, 2025 | 19.35 Mn |
| Mar 31, 2025 | 19.35 Mn |
| Dec 31, 2024 | 22.11 Mn |
| Dec 31, 2024 | 22.11 Mn |
| Sep 30, 2024 | 24.27 Mn |
| Sep 30, 2024 | 24.27 Mn |
| Jun 30, 2024 | 20.24 Mn |
| Jun 30, 2024 | 20.24 Mn |
| Mar 31, 2024 | 22.31 Mn |
| Mar 31, 2024 | 22.31 Mn |
| Dec 31, 2023 | 27.12 Mn |
| Dec 31, 2023 | 27.12 Mn |
| Sep 30, 2023 | 21.59 Mn |
| Sep 30, 2023 | 21.59 Mn |
| Jun 30, 2023 | 21.67 Mn |
| Jun 30, 2023 | 21.67 Mn |
| Mar 31, 2023 | 15.37 Mn |
| Mar 31, 2023 | 15.37 Mn |
| Dec 31, 2022 | 13.32 Mn |
| Dec 31, 2022 | 13.32 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Dec 31, 2021 | -20.08 Mn |
| Dec 31, 2021 | -20.08 Mn |
| Sep 30, 2021 | -3.38 Mn |
| Sep 30, 2021 | -3.38 Mn |
| Jun 30, 2021 | -5.68 Mn |
| Jun 30, 2021 | -5.68 Mn |
| Mar 31, 2021 | -8.02 Mn |
| Mar 31, 2021 | -8.02 Mn |
| Dec 31, 2020 | -10.98 Mn |
| Dec 31, 2020 | -10.98 Mn |
| Sep 30, 2020 | -5.20 Mn |
| Sep 30, 2020 | -5.20 Mn |
| Jun 30, 2020 | -6.32 Mn |
| Jun 30, 2020 | -6.32 Mn |
| Mar 31, 2020 | -4.40 Mn |
| Mar 31, 2020 | -4.40 Mn |